OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Following the Map of the Genome: The Biotechnology Industry and its Future
All welcome, staff, students and public
Donald Drakeman, JD, PhD, is a Venture Partner with Advent Life Sciences and a Fellow in Health Management at the University of Cambridge. He was the founding CEO of the biotechnology company that pioneered the field of ‘checkpoint inhibitors’, leading to multiple new treatments for cancer. He is a Distinguished Research Professor in Constitutional Studies at the University of Notre Dame.
Lisa Drakeman, PhD, is the Chair of Volunteers in Medicine, a large charitable clinic for the medically underserved located in coastal South Carolina. She was the founding CEO of a biotechnology company in Europe and the U.S. which set numerous biotechnology financing records and developed a new FDA-approved treatment for cancer. She is a Certified Sommelier.
Date:
10 June 2015, 17:00
Venue:
Rothermere American Institute, 1A South Parks Road OX1 3UB
Speakers:
Donald Drakeman (Advent Life Sciences and University of Cambridge / Volunteers in Medicine),
Lisa Drakeman (Advent Life Sciences and University of Cambridge / Volunteers in Medicine)
Part of:
Medical Sciences Division Events
Booking required?:
Not required
Audience:
Public
Editor:
Alison Brindle
